Your browser doesn't support javascript.
loading
Comment on: Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial: reply.
Sircar, Geetabali; Goswami, Rudra Prosad; Sircar, Dipankar; Ghosh, Alakendu; Ghosh, Parasar.
Affiliation
  • Sircar G; Department of Rheumatology, Institute of Postgraduate Medical Education and Research, Kolkata.
  • Goswami RP; Department of Rheumatology, Institute of Postgraduate Medical Education and Research, Kolkata.
  • Sircar D; Department of Nephrology, Institute of Postgraduate Medical Education and Research, Kolkata.
  • Ghosh A; Department of Rheumatology, Institute of Postgraduate Medical Education and Research, Kolkata.
  • Ghosh P; Department of Rheumatology, Institute of Postgraduate Medical Education and Research, Kolkata.
Rheumatology (Oxford) ; 58(5): 929, 2019 05 01.
Article in En | MEDLINE | ID: mdl-30933265
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2019 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2019 Document type: Article Country of publication: United kingdom